Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria Smaragdi"'
Autor:
Ioanna Gazouli, Stavros Tsampalas, Ioannis Tsimaris, Georgios Zarkavelis, Nikolaos Grivas, Eleftherios Kampletsas, Alexandra Papadaki, Leonidas Mavroeidis, Panagiotis Ntellas, Stefania Gkoura, Lampriani Tsali, Anna-Lea Amylidi, Maria Smaragdi Vlachou, Davide Mauri
Publikováno v:
Urology Annals, Vol 13, Iss 1, Pp 86-88 (2021)
Testicular metastases from ureteral carcinoma are rare and they are generally mimic orchiepididymitis. For this reason, these are associated to misleading diagnoses and cancer treatment delay. We believe that both timing and knowledge of genital bloo
Externí odkaz:
https://doaj.org/article/e1685abd1ae546a481862f5781d9df54
Autor:
Zoe Apalla, Eftychios Psarakis, Aimilios Lallas, Alexia Koukouthaki, Athanassios Fassas, Maria Smaragdi
Publikováno v:
Dermatology Practical & Conceptual, Vol 9, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/a5f7175648b64ccf951595665b8ec48b
Autor:
Leonidas Mavroeidis, Panagiotis Ntellas, Eleftherios Kampletsas, Maria Smaragdi Vlachou, Anna-Lea Amylidi, Georgios Zarkavelis, Ioannis Tsimaris, Stavros Tsampalas, Lampriani Tsali, Nikolaos Grivas, Alexandra Papadaki, Ioanna Gazouli, Stefania Gkoura, Davide Mauri
Publikováno v:
Urology Annals, Vol 13, Iss 1, Pp 86-88 (2021)
Urology Annals
Urology Annals
Testicular metastases from ureteral carcinoma are rare and they are generally mimic orchiepididymitis. For this reason, these are associated to misleading diagnoses and cancer treatment delay. We believe that both timing and knowledge of genital bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6812e00434b686c8d933a58ba78baaba
http://www.urologyannals.com/article.asp?issn=0974-7796
http://www.urologyannals.com/article.asp?issn=0974-7796
Autor:
Ioanna, Gazouli, Dimitris, Baltogiannis, Panagiotis, Ntellas, Maria, Smaragdi Vlachou, Christos, Tagkas, Ioannis, Champilomatis, Εleftherios, Kampletsas, Maria, Tolia, Davide, Mauri
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(4)
Glucose-6 phosphate dehydrogenase (G6PD) deficiency has an estimated prevalence of 5 -7.5% of the global population. Administration of some drugs in G6PD deficient patients may result in clinical conditions of varying severity, including potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8395cf4e147f67e1c04fec48d744e9c2
https://pubmed.ncbi.nlm.nih.gov/34565030
https://pubmed.ncbi.nlm.nih.gov/34565030
Autor:
Evaggelia Kampouropoulou, Aimilios Lallas, Elizabeth Lazaridou, Zoe Apalla, Theodoros Sidiropoulos, Marina Papageorgiou, Maria Smaragdi, Florentina Delli
Publikováno v:
European journal of dermatology : EJD. 30(6)
Omalizumab is approved for the treatment of chronic spontaneous urticaria (CSU) not responding to antihistamines. Data on omalizumab use in real-world settings and in different populations are lacking. To record our five-year experience of omalizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85156b7e3f8bcd09b28654285c99300b
https://pubmed.ncbi.nlm.nih.gov/33258453
https://pubmed.ncbi.nlm.nih.gov/33258453
Autor:
Athanassios Fassas, Aimilios Lallas, Alexia Koukouthaki, Zoe Apalla, Eftychios Psarakis, Maria Smaragdi
Publikováno v:
Dermatology Practical & Conceptual, Vol 9, Iss 4 (2019)
Concomitant cancers in psoriasis patients often pose significant limitations in treatment decision. In contrast to the majority of the available systemic antipsoriatic drugs, apremilast is not contraindicated in case of previous or concomitant malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e4941bc5e4e8a9296bfa97fcbfa7f3
https://europepmc.org/articles/PMC6830556/
https://europepmc.org/articles/PMC6830556/
Autor:
Gazouli I; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Tsampalas S; Department of Urology, University Hospital of Ioannina, Ioannina, Greece., Tsimaris I; Department of Urology, Chatzikosta General Hospital, Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Grivas N; Department of Urology, Chatzikosta General Hospital, Ioannina, Greece.; European Board of Urology, PanHellenic Association for Continual Medical Research, Ioannina, Greece., Kampletsas E; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Papadaki A; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Mavroeidis L; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Ntellas P; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Gkoura S; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Tsali L; PACMeR Athens, PanHellenic Association for Continual Medical Research, Ioannina, Greece., Amylidi AL; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece., Vlachou MS; Medical School, University of Ioannina, Ioannina, Greece., Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.; EMEKEN, Society for Study of Clonal Heterogeneity of Neoplasia, Ioannina, Greece.
Publikováno v:
Urology annals [Urol Ann] 2021 Jan-Mar; Vol. 13 (1), pp. 86-88. Date of Electronic Publication: 2021 Jan 19.